JNJ

Johnson & Johnson

Healthcare
271.19 up +5.34 +2.01% Pre-Market
2026-09-01 • USD

Key Metrics

Market Cap 653.54B
EV 681.82B
Shares Out 2.41B
Revenue (ttm) 97.93B
Net Income 21.04B
Beta
P/E
Forward P/E
EPS (ttm) $8.61
P/S 6.67
P/B 7.68
P/FCF 29.35
P/C 23.65
EV/Sales 6.96
EV/EBITDA
ROA 10.46%
ROE 25.74%
ROIC
Gross Margin 67.91%
Oper. Margin
Profit Margin 21.48%
Debt/Eq 0.58
LT Debt/Cap 30.53%
Quick Ratio 0.73
Current Ratio 1.09
Book/sh 35.3
Cash/sh 8.48
Div Yield 1.93%
Div TTM $5.24
Payout Ratio 60.86%
SMA20 2.14%
SMA50 4.43%
SMA200 15.58%
Volume 6,035,314
Avg Volume 7.77M
Rel Volume 0.78
Perf Week 2.04%
Perf Month 6.60%
Perf Quarter 21.48%
Perf Half Y 9.90%
Perf YTD 31.04%
Perf Year 52.35%
Perf 3Y 68.99%
Perf 5Y 54.93%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $1.3400
TTM Yield 1.93%
TTM Amount $5.24
Payout Ratio 60.86%
3-Yr Growth (CAGR) 4.92%
5-Yr Growth (CAGR) 5.25%

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-28 $1.3400
Q1 2026 ~2026-03-29 $1.3000
Q4 2025 ~2025-12-28 $1.3000
Q3 2025 ~2025-09-28 $1.3000
Q2 2025 ~2025-06-29 $1.3000
Q1 2025 ~2025-03-30 $1.2400
Q4 2024 ~2024-12-29 $1.2400
Q3 2024 ~2024-09-29 $1.2400
Q2 2024 ~2024-06-30 $1.2400
Q1 2024 ~2024-03-31 $1.1900
Q4 2023 ~2023-12-31 $1.1900
Q3 2023 ~2023-10-01 $1.1900

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Johnson & Johnson is a leading global healthcare company engaged in the research, development, manufacture, and sale of a wide range of products in three segments: Innovative

Name
Johnson & Johnson
Industry
Drug Manufacturers - General
CEO
Joaquin Duato · Chairman of the Board and Chief Executive Officer
Employees
130,000 as of 2025-12-28
IPO Date
2018-02-15
Phone
(732) 524-0400
Address
One Johnson & Johnson Plaza, New Brunswick, NJ 08933
Website
www.jnj.com

Key Executives

Name Title FY Pay
Deirdre Connelly Executive Vice President
Peter Fasolo Executive Vice President
James Young Executive Vice President
Michael Ullem Vice President
Joaquin Duato Chairman of the Board and Chief Executive Officer

Latest News